Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

ERDU:GR

31.9300 EUR 0.5100 1.62%

As of 07:26:01 ET on 03/03/2015.

Snapshot for BlackRock Global Funds - World Healthscience Fund (ERDU)

Open: 31.6200 High - Low: 31.9300 - 31.5700 Primary Exchange: Berlin
Volume: 0 52-Week Range: 19.1800 - 32.2400 Beta vs NDWUHC: 0.9518

ETF Chart for ERDU

No chart data available.
  • ERDU:GR 31.7020
  • 1D
  • 1M
  • 1Y
31.4200
Interactive ERDU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ERDU

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 2001-07-25 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for ERDU

NAV -
Assets (M) (on 2015-01-30) 3,250.8640
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for ERDU

No dividends reported

Performance for ERDU

1-Month +5.05% 1-Year +47.17%
3-Month +14.22% 3-Year +33.89%
Year To Date +14.05% 5-Year +22.34%
Expense Ratio 1.82

Top Fund Holdings for ERDU

Filing Date: 01/30/2015
Name Position Value % of Total
Novartis AG 1,264,600 123,910,320 3.942%
Biogen Idec Inc 275,407 107,177,388 3.409%
Celgene Corp 882,808 105,195,401 3.346%
Merck & Co Inc 1,647,100 99,287,188 3.158%
UnitedHealth Group Inc 907,026 96,371,512 3.066%
Alexion Pharmaceuticals Inc 502,968 92,163,856 2.932%
Johnson & Johnson 907,800 90,907,092 2.892%
Amgen Inc 574,900 87,534,274 2.785%
Actavis plc 325,592 86,783,292 2.761%
Roche Holding AG 320,400 86,572,947 2.754%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil